will participate in the 2024 Bio International Convention, the largest biopharmaceutical exhibition in the industry, to showcase its contract-based drug manufacturing and development capabilities, the company said Monday.The Bio International Convention, also known as Bio USA, will be held in San Diego from June 3 to 6. This year, more than 1,500 companies and nearly 20,000 attendees are expected to join the event to discuss partnerships.Samsung Biologics, which will participate in the event with an independent booth for the 12th consecutive year, said it plans to conduct business networking through various content and events.At the exhibition, the company will decorate its booth with LED panels showing various videos highlighting its competitiveness as a contract development and manufacturing organization (CDMO) company. CDMO refers to a business that develops and manufactures drugs for client companies.

“At the event, our booth will highlight our biopharmaceutical production capacity, which is the largest in the industry, our contract development organization (CDO) platform services and our expanding antibody-drug conjugate (ADC) portfolio,” the company said.The company will also introduce a new slogan for its CDO business, “Agile. Flexible. Focused on You,” at the event, adding that it will use the event to showcase its ability to provide customized drug development services for clients.To raise brand awareness during the event, Samsung Biologics will also conduct sponsorship activities in San Diego. More than 140 banners will be installed on Harbor Drive, the main road leading from the San Diego Airport to the exhibition center, and streetlights near the exhibition center, and four digital banner video ads will be displayed in the main lobby of 안전 the exhibition center, the company said.